Clinical trial Recruiting at 1 site Interventional Ages 18 to 65 Women only

PEMM for women with chronic low back pain and urinary leakage

Official title: Effects of PEMM in Chronic Low Back Pain Women With Urinary Incontinence A Randomised Controlled Trial

Run by Hamad Medical Corporation · NCT07351851 · Data updated 2026-11-12

This study will try pelvic external myofascial mobilization (PEMM) with core exercises to see if it lowers pain, reduces disability, and improves urinary leakage and mental health in women with chronic low back pain and urinary incontinence.

More Pelvic Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexWomen only
Enrollment200 (estimated)
SponsorHamad Medical Corporation
Industry-sponsored
Locations1 site (Doha, Baladiyat ad Dawhah)
StatusRecruiting
StartedSeptember 29, 2025
Main results expectedDecember 2027
Study endsDecember 2027
Registry record updatedJanuary 20, 2026
Trial IDNCT07351851 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–65 with chronic low back pain lasting more than three months, urinary incontinence for at least three months, moderate-to-severe pain (NRS >5), and referred for physiotherapy are ideal candidates.

Probably not a fit

Women who are pregnant or within one year postpartum, have active urinary tract infection, prior pelvic floor surgery, systemic renal or cardiac conditions, active cancer, inflammatory disease, or red-flag back conditions are unlikely to be eligible or benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional, randomized study compares pelvic external myofascial mobilization (PEMM) delivered with a Theragun plus core exercises against a control condition in women who have chronic low back pain and urinary incontinence. Participants are randomly assigned using simple randomization and receive physiotherapy-based PEMM as the experimental intervention. Primary outcomes include reductions in disability and pain and improvements in mental health and urinary symptoms. The trial is conducted at Hamad Medical Corporation in Doha and enrolls adult women meeting clinical pain and incontinence criteria.

Why it matters

Potential benefit: If successful, PEMM could reduce pain and disability and improve urinary control and mental well-being for women with coexisting chronic low back pain and urinary incontinence.

How similar studies have gone: Some prior work in men and in other musculoskeletal/fascial conditions has suggested benefits from external myofascial mobilization, but evidence specifically addressing women with both chronic low back pain and urinary incontinence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age group of 18 - 65 years
* Has child/children \<5 parity
* CLBP patients with UI referred for physiotherapy for CLBP
* Patient with low back pain for more than 3 months
* NRS more than 5/10
* Patient with complain of urinary incontinence since past 3 months or more

Exclusion Criteria:

* Chronic Low Back Pain with red flags
* Not able to read and write in English /Arabic
* Pregnant ladies and post partum 1 year
* UTI, Pelvic floor Surgery
* Any systemic condition of renal and cardiac
* Patient with active carcinoma or any inflammatory disease

Where it's running

  • Hamad Medical Corporation
    Doha, Baladiyat ad Dawhah, Qatar
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.